By Glenn Dobson, CEO, The Drug Detection Agency Group Recent policy decisions in the Australian Capital Territory (ACT), centred on Canberra, have seen the decriminalisation of possession of small amounts of illicit drugs, including cocaine, methamphetamine, MDMA, LSD...
Uncategorized
Australian treatments proceed as US advisory panel rejects evidence behind MDMA treatment for PTSD
Click image for article by Natasha Robinson, The Australian
An alert has been put out in New Zealand for a new synthetic cannabinoid being misrepresented as a benzodiazepine. This highlights the dangers of synthetic drugs being marketed as another type of drug creating the high potential of harm to users.
https://www.highalert.org.nz/alerts-and-notifications/new-synthetic-cannabinoid-misrepresented-as-a-benzodiazepinehttps://www.highalert.org.nz/alerts-and-notifications/new-synthetic-cannabinoid-misrepresented-as-a-benzodiazepine



